Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10412-10420

  Jegaskanda, S ^a   Ahn, S H ^b,c   Skinner, N ^a,d   Thompson, A J ^a,b,d   Ngyuen, T ^b,d   Holmes, J ^b,d   de Rose, R ^a   Navis, M ^a   Winnall, W R ^a   Kramski, M ^a   Bernardi, G ^a   Bayliss, J ^b   Colledge, D ^b   Sozzi, V ^b   Visvanathan, K ^a,d   Locarnini, S A ^b   Kent, S J ^a   Revill, P A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^c Yonsei University College of Medicine   (South Korea)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CORE PROTEIN; GAMMA INTERFERON; HEPATITIS E ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18; PROTEIN P21; HEPATITIS B(E) ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HEPATITIS B; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREGULATION; IN VITRO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; CELL CULTURE; GENETICS; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; VIROLOGY; YOUNG ADULT;

ADULT; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84906330275     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00111-14     Document Type: Article

References (33)

1. Ait-Goughoulte M, Lucifora J, Zoulim F, Durantel D. 2010. Innate antiviral immune responses to hepatitis B virus. Viruses 2:1394-1410. http://dx.doi.org/10.3390/v2071394.
2. Revill P, Yuan Z. 2013. New insights into how hepatitis B virus manipulates the innate immune response to establish acute and persistent infection. Antiviral Ther. 18(1):1-15. http://dx.doi.org/10.3851/IMP2542.
3. Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, Bosse E, Iqbal J, Hussain MM, Balschun K, Rocken C, Arlt A, Gunther R, Hampe J, Schreiber S, Baron JL, Moody DB, Liang TJ, Blumberg RS. 2012. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 18:1060-1068. http://dx.doi.org/10.1038/nm.2811.
4. Thompson AJ, Colledge D, Rodgers S, Wilson R, Revill P, Desmond P, Mansell A, Visvanathan K, Locarnini S. 2009. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro. Antivir. Ther. 14:797-808. http://dx.doi.org/10.3851/IMP1294.
5. Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. 2011. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J. Hepatol. 55:762-769. http://dx.doi.org/10.1016/j.jhep.2010.12.042.
6. Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S. 2007. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 45:102-110. http://dx.doi.org/10.1002/hep.21482.
7. Wilson R, Warner N, Ryan K, Selleck L, Colledge D, Rodgers S, Li K, Revill P, Locarnini S. 2011. The hepatitis B e antigen suppresses IL-1betamediated NF-kappaB activation in hepatocytes. J. Viral Hepat. 18:e499-e507. http://dx.doi.org/10.1111/j.1365-2893.2011.01484.x.
8. Messageot F, Salhi S, Eon P, Rossignol JM. 2003. Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences. J. Biol. Chem. 278:891-895. http://dx.doi.org/10.1074/jbc.M207634200.
9. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. 1998. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10:259-264. http://dx.doi.org/10.1016/S0952-7915(98)80163-5.
10. Cheung H, Chen NJ, Cao Z, Ono N, Ohashi PS, Yeh WC. 2005. Accessory protein-like is essential for IL-18-mediated signaling. J. Immunol. 174:5351-5357. http://dx.doi.org/10.4049/jimmunol.174.9.5351.
11. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. 2002. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J. Virol. 76:10702-10707. http://dx.doi.org/10.1128/JVI.76.21.10702-10707.2002.
12. Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. 2002. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J. Virol. 76:5646-5653. http://dx.doi.org/10.1128/JVI.76.11.5646-5653.2002.
13. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV. 2005. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci. U. S. A. 102:9913-9917. http://dx.doi.org/10.1073/pnas.0504273102.
14. Zhang Y, Li Y, Ma Y, Liu S, She Y, Zhao P, Jing M, Han T, Yan C, Wu Z, Gao J, Ye L. 2011. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cell metastasis. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G565-G573. http://dx.doi.org/10.1152/ajpgi.00058.2011.
15. Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65. http://dx.doi.org/10.1146/annurev.immunol.19.1.65.
16. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. 2011. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 54:209-218. http://dx.doi.org/10.1016/j.jhep.2010.07.009.
17. Reference deleted.
18. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, Dunn C, Pallant C, Ellis G, Khanna P, Dusheiko G, Gilson RJ, Maini MK. 2010. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 6:e1001227. http://dx.doi.org/10.1371/journal.ppat.1001227.
19. Schlaak JF, Tully G, Lohr HF, Gerken G, Meyer zum Buschenfelde KH. 1999. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro-and anti-inflammatory cytokines. Clin. Exp. Immunol. 115:508-514. http://dx.doi.org/10.1046/j.1365-2249.1999.00812.x.
20. Locarnini S, Shaw T, Dean J, Colledge D, Thompson A, Li K, Lemon SM, Lau GG, Beard MR. 2005. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J. Clin. Virol. 32:113-121. http://dx.doi.org/10.1016/j.jcv.2004.10.002.
21. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA. 2010. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 51:1933-1944. http://dx.doi.org/10.1002/hep.23571.
22. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1715-1720.
23. Cabuang LM, Shaw T, Littlejohn M, Colledge D, Sozzi V, Soppe S, Warner N, Thompson A, Preiss S, Lam N, Walsh R, Lewin SR, Thio CL, Matthews G, Locarnini SA, Revill PA. 2012. In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV coinfection. J. Med. Virol. 84:1166-1176. http://dx.doi.org/10.1002/jmv.23328.
24. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O'Neill LA. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 97:10162-10167. http://dx.doi.org/10.1073/pnas.160027697.
25. Wu S, Kanda T, Imazeki F, Arai M, Yonemitsu Y, Nakamoto S, Fujiwara K, Fukai K, Nomura F, Yokosuka O. 2010. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunol. 23:467-476. http://dx.doi.org/10.1089/vim.2010.0042.
26. Ganz M, Csak T, Nath B, Szabo G. 2011. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J. Gastroenterol. 17:4772-4778. http://dx.doi.org/10.3748/wjg.v17.i43.4772.
27. Asakawa M, Kono H, Amemiya H, Matsuda M, Suzuki T, Maki A, Fujii H. 2006. Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection. Int. J. Cancer 118:564. http://dx.doi.org/10.1002/ijc.21367.
28. Milich DR, Chen MK, Hughes JL, Jones JE. 1998. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. 160:2013-2021.
29. Maini MK, Peppa D. 2013. NK cells: a double-edged sword in chronic hepatitis B virus infection. Front. Immunol. 4:57. http://dx.doi.org/10.3389/fimmu.2013.00057.
30. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H. 1997. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623. http://dx.doi.org/10.1038/386619a0.
31. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. http://dx.doi.org/10.4049/jimmunol.168.9.4531.
32. Yang CY, Kuo TH, Ting LP. 2006. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J. Biol. Chem. 281:34525-34536. http://dx.doi.org/10.1074/jbc.M510981200.
33. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550. http://dx.doi.org/10.1146/annurev.immunol.021908.132612.